The FDA is running out of National Drug Code (NDC) numbers, and that means within the next 15 years, the U.S. healthcare community will experience an NDC shortage!
Patricia Milazzo, RPh, senior director of embedded content with Clinical Effectiveness at Wolters Kluwer, Health, has been following this issue and took part in the FDA hearings.
She offers insight on:
FDA options for the new NDC
Recoding your drug data systems
Planning ahead for the change